New York, NY / ACCESSWIRE / October 23, 2014 / MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) today published a new blog post on The Chairman's Blog, written by the Company's President and Chief Executive Officer, David Hansen. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Mr. Hansen discusses MabVax's latest advances and goals moving forward following the completion of the Company's "reverse merger" with Telik, Inc. In his inaugural blog, he writes, "We have made significant progress on advancing our programs over the last few months and certainly plan to continue over the next year as we take important steps forward in putting three more products into the clinic." Read the full blog post from Mr. Hansen on TheChairmansBlog.com (http://www.thechairmansblog.com/mabvax-therapeutics/david-hansen/introducing-mabvax-therapeutics).

About MabVax Therapeutics

MabVax Therapeutics, Inc., (OTCQB: MBVX) became a public company on July 8th of this year through a merger with a listed company and changed its name to MabVax Therapeutics Holdings, Inc. MabVax is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. Therapeutic vaccines under development were discovered at MSKCC and are exclusively licensed to MabVax prior to the merger. Additional information about the Company, please visit www.mabvax.com and connect with the Company on Twitter, LinkedIn, Facebook, and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com




SOURCE: Market Exclusive IR